Filing metadata

Accession number
0001328143-21-000057
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Jun 04, 2021
Reporting period
Jun 02, 2021
Description
Insider transaction

Explore SEC Filings Hub